Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand
© 2016 Permsuwan et al. Background: The management of type 2 diabetes mellitus (T2DM) in elderly population poses many challenges. Dipeptidyl peptidase-4 (DPP-4) inhibitors show particular promise due to excellent tolerability profiles, low risk of hypoglycemia, and little effect on body weight. Thi...
Saved in:
Main Authors: | Permsuwan U., Dilokthornsaku P., Saokaew S., Thavorn K., Chaiyakunapruk N. |
---|---|
Format: | Journal |
Published: |
2017
|
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84989173753&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/41518 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand
by: Unchalee Permsuwan, et al.
Published: (2018) -
Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in Thailand
by: Permsuwan U., et al.
Published: (2017) -
Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in Thailand
by: Unchalee Permsuwan, et al.
Published: (2018) -
Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy versus sulfonylurea monotherapy for people with type 2 diabetes and chronic kidney disease in Thailand
by: Unchalee Permsuwan, et al.
Published: (2018) -
Navigating the chemical space of dipeptidyl peptidase-4 inhibitors
by: Watshara Shoombuatong, et al.
Published: (2015)